拜耳公司。美國最高法院駁回化學品製造商的除草劑上訴

3個月前
拜耳公司。美國最高法院駁回化學品製造商的除草劑上訴

法官們說他們不會審理此案,而是保留了一項裁決,即維持對加州一名Roundup用戶2500萬美元的賠償,該用戶聲稱他在自己的土地上使用基於草甘膦的產品導致了他的癌症。

周二,拜耳公司說它 "恭敬地 "不同意法院的裁決,說它 "破壞了公司依靠專家監管機構採取的官方行動的能力"。

拜耳公司面臨的法律索賠集中在草甘膦可能的致癌風險上,草甘膦是Roundup和許多其他除草劑所基於的除草劑。

2015年,世界衛生組織認定草甘膦 "可能對人類致癌",但它在美國和包括歐洲在內的其他地方仍然獲得批准。

在上周的另一起案件中,一個聯邦上訴法院裁定,美國環境保護局沒有充分考慮草甘膦對人類和環境造成的風險,這可能迫使監管機構再次進行審查。

作為2018年以630億美元收購孟山都的一部分,拜耳收購了Roundup品牌,它一直堅持認為這種化學品是安全的。

在向法院提出的上訴中,拜耳表示,"當幾乎普遍的科學和監管共識是該產品不會導致癌症時",它不應該因為營銷產品而受到懲罰。

它指出,在2019年,環境保護局甚至指示製造商不要在其標籤上添加癌症警告,說這樣做會產生誤導。

該公司在審判中輸掉了三起Roundup案件--包括引發其最高法院上訴的那起案件--同時贏得了四起。

在3月份給投資者的更新中,拜耳說它已經解決了約13.8萬個案件中的約10.7萬個案件。

拜耳表示,它正計劃用其他活性成分取代草甘膦,用於面向美國住宅市場的除草劑。


The judges said they would not hear the case, leaving in place a ruling upholding a $25m award to a Roundup user in California, who had claimed that his use of the glyphosate-based product on his property led to his cancer.

On Tuesday, Bayer said it "respectfully" disagreed with the court's decision, saying it "undermined the ability of companies to rely on official actions taken by expert regulatory agencies".

Bayer is facing legal claims focused on the possible carcinogenic risks of glyphosate, the herbicide that Roundup and many other weedkillers are based on.

In 2015, the World Health Organization determined that glyphosate was "probably carcinogenic to humans", but it remains approved in the US and elsewhere, including Europe.

In a separate case last week, a federal appeals court ruled that the US Environmental Protection Agency had not adequately considered the risks to humans and the environment caused by glyphosate, which could force another review by regulators.

Bayer, which acquired the Roundup brand as part of its $63bn takeover Monsanto in 2018, has maintained that the chemical is safe.

In its appeal to the court, Bayer said it should not be exposed to punishment for marketing a product "when the near-universal scientific and regulatory consensus is that the product does not cause cancer".

It noted that in 2019, the Environmental Protection Agency even instructed manufacturers not to add cancer warnings to their labels, saying to do so would be misleading.

The company has lost three Roundup cases at trial - including the one that triggered its Supreme Court appeal - while winning four.

In a March update to investors, Bayer said it had resolved about 107,000 cases out of about 138,000 cases overall.

Bayer has said it is planning to replace glyphosate with other active ingredients for herbicides geared to the residential market in the US.

編輯精選

熱門新聞